CRISPR‐Cas9: how research on a bacterial RNA‐guided mechanism opened new perspectives in biotechnology and biomedicine. Issue 4 (21st March 2015)

• Record Type: Journal Article
• Authors: Charpentier, Emmanuelle
• Is Part Of: EMBO molecular medicine. Volume 7:Issue 4(2015:Apr.)
• Page Start: 363
• Page End: 365
• Publication Date: 2015-03-21
• Subjects: Molecular biology -- Periodicals; Medical genetics -- Periodicals; Pathology, Molecular -- Periodicals; 616.04205
• DOI: 10.15252/emmm.201504847
• Languages: English
• ISSNs: 1757-4676

Abstract

<abstract abstract-type="graphical" id="emmm201504847-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The 2015 Louis‐Jeantet Prize for Medicine winner Emmanuelle Charpentier describes the CRISPR‐Cas9 unique mechanism. The system was harnessed into a new tool that makes genome editing within the cell a simple and straightforward system. <boxed-text content-type="graphic" id="emmm201504847-blkfxd-0001" position="anchor" orientation="portrait"><graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgjf84rx0p" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></boxed-text></p> </abstract>